Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.70%

Stock Markets Apr 25, 2022 21:25
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.70%

Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Consumer Services and Healthcare sectors propelled shares higher.

At the close in NYSE, the Dow Jones Industrial Average rose 0.70%, while the S&P 500 index climbed 0.57%, and the NASDAQ Composite index gained 1.29%.

The biggest gainers of the session on the Dow Jones Industrial Average were Johnson & Johnson (NYSE:JNJ), which rose 2.46% or 4.47 points to trade at 186.01 at the close. Microsoft Corporation (NASDAQ:MSFT) added 2.44% or 6.69 points to end at 280.72 and American Express Company (NYSE:AXP) was up 1.97% or 3.56 points to 184.10 in late trade.

Biggest losers included Verizon Communications Inc (NYSE:VZ), which lost 3.14% or 1.63 points to trade at 50.28 in late trade. Chevron Corp (NYSE:CVX) declined 2.15% or 3.46 points to end at 157.49 and Nike Inc (NYSE:NKE) shed 0.88% or 1.13 points to 127.94.

The top performers on the S&P 500 were Moderna Inc (NASDAQ:MRNA) which rose 7.18% to 150.41, Match Group Inc (NASDAQ:MTCH) which was up 6.70% to settle at 82.48 and Fortinet Inc (NASDAQ:FTNT) which gained 6.31% to close at 323.49.

The worst performers were Charles River Laboratories (NYSE:CRL) which was down 7.21% to 253.34 in late trade, Schlumberger NV (NYSE:SLB) which lost 7.11% to settle at 38.69 and Halliburton Company (NYSE:HAL) which was down 6.26% to 35.33 at the close.

The top performers on the NASDAQ Composite were Nkarta Inc (NASDAQ:NKTX) which rose 140.93% to 18.72, Rubius Therapeutics Inc (NASDAQ:RUBY) which was up 40.60% to settle at 1.87 and Erytech Pharma SA ADR (NASDAQ:ERYP) which gained 37.70% to close at 1.68.

The worst performers were Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) which was down 56.17% to 0.79 in late trade, Eliem Therapeutics Inc (NASDAQ:ELYM) which lost 55.76% to settle at 2.88 and Toughbuilt Industries Inc (NASDAQ:TBLT) which was down 44.87% to 14.57 at the close.

Declining stocks outnumbered rising ones by 1722 to 1520 and 117 ended unchanged; on the Nasdaq Stock Exchange, 2178 rose and 1715 declined, while 237 ended unchanged on the New York Stock Exchange.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 4.22% to 27.02.

In commodities trading, Gold Futures for June delivery was down 1.84% or 35.55 to $1,898.75 a troy ounce. Meanwhile, Crude oil for delivery in June fell 3.09% or 3.15 to hit $98.92 a barrel, while the July Brent oil contract fell 3.38% or 3.59 to trade at $102.56 a barrel.

EUR/USD was down 0.76% to 1.07, while USD/JPY fell 0.38% to 128.07.

The US Dollar Index Futures was up 0.53% at 101.75.

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.70%
 

Related Articles

Dow futures Dip After Strong Jobs Report
Dow futures Dip After Strong Jobs Report By Investing.com - Aug 08, 2022 1

By Oliver Gray Investing.com - U.S. stock futures were trading lower during Sunday’s evening deals, with major benchmark averages coming off a positive week as stronger than...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email